A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing-Reference-Cited by-同舟云学术

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing

Published:1997-12 Issue:14 Volume:33 Page:2390-2392
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Dørum A,Møller P,Kamsteeg E.J,Scheffer H,Burton M,Heimdal K.R,Mæhle L.O,Hovig E,Tropé C.G,van der Hout A.H,van der Meulen M.A,Buys C.H.C.M,te Meerman G.J

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Genetic epidemiology of the breast cancer in Britain;Iselius;Ann Human Genet,1991

2. Genetic epidemiology of breast cancer: segregation analysis of 200 Danish pedigrees;Williams;Genet Epidemiol,1984

3. Miki Y, Swensen J, Shattruck-Eidens E, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266, 66–71.

4. Wooster R, Neuhausen SL, Mangion J, et al. Localization of breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994, 265, 2088–2090.

5. Evidence for a third breast cancer susceptibility gene;Sobol;Lancet,1994

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer;JCO Precision Oncology;2020-11

2. Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico;Cancer Genetics;2012-05

3. Haplotype Sharing Methods;eLS;2010-09-15

4. TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival;BMC Cancer;2005-10-17

5. Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families;Human Genetics;2005-05-10